94 related articles for article (PubMed ID: 18684028)
1. Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006.
Moriarty AT; Schwartz MR; Eversole G; Means M; Clayton A; Souers R; Fatheree L; Tench WD; Henry M; Wilbur DC
Arch Pathol Lab Med; 2008 Aug; 132(8):1290-4. PubMed ID: 18684028
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus testing and reporting rates in 2012: results of a College of American Pathologists national survey.
Zhao C; Moriarty AT; Ghofrani M; Husain M; Tambouret RH; Laucirica R; Laser A; Fischer A; Ocal IT; Souers RJ; Russell DK; Fan F; Crothers BA
Arch Pathol Lab Med; 2015 Jun; 139(6):757-61. PubMed ID: 25436905
[TBL] [Abstract][Full Text] [Related]
3. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
Davey DD; Neal MH; Wilbur DC; Colgan TJ; Styer PE; Mody DR
Arch Pathol Lab Med; 2004 Nov; 128(11):1224-9. PubMed ID: 15504056
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey.
Zhao C; Crothers BA; Ghofrani M; Li Z; Souers RJ; Hussain M; Fan F; Ocal IT; Goodrich K; Shen R; Davey DD;
Arch Pathol Lab Med; 2016 Dec; 140(12):1364-1370. PubMed ID: 27479334
[TBL] [Abstract][Full Text] [Related]
5. Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006.
Eversole GM; Moriarty AT; Schwartz MR; Clayton AC; Souers R; Fatheree LA; Chmara BA; Tench WD; Henry MR; Wilbur DC
Arch Pathol Lab Med; 2010 Mar; 134(3):331-5. PubMed ID: 20196659
[TBL] [Abstract][Full Text] [Related]
6. Bethesda 2014 Implementation and Human Papillomavirus Primary Screening: Practices of Laboratories Participating in the College of American Pathologists PAP Education Program.
Davey DD; Souers RJ; Goodrich K; Mody DR; Tabbara SO; Booth CN
Arch Pathol Lab Med; 2019 Oct; 143(10):1196-1202. PubMed ID: 31021657
[TBL] [Abstract][Full Text] [Related]
7. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
8. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
[TBL] [Abstract][Full Text] [Related]
9. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
10. Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5.
Booth CN; Bashleben C; Filomena CA; Means MM; Wasserman PG; Souers RJ; Henry MR
Arch Pathol Lab Med; 2013 Feb; 137(2):214-9. PubMed ID: 23368863
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.
J Natl Cancer Inst; 2000 Mar; 92(5):397-402. PubMed ID: 10700419
[TBL] [Abstract][Full Text] [Related]
12. ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy.
Siddiqui MT; Hornaman K; Cohen C; Nassar A
Arch Pathol Lab Med; 2008 Oct; 132(10):1648-52. PubMed ID: 18834224
[TBL] [Abstract][Full Text] [Related]
13. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
[TBL] [Abstract][Full Text] [Related]
15. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: review of ancillary testing modalities and implications for follow-up.
Davey DD; Greenspan DL; Kurtycz DF; Husain M; Austin RM
J Low Genit Tract Dis; 2010 Jul; 14(3):206-14. PubMed ID: 20592556
[TBL] [Abstract][Full Text] [Related]
16. Atypical Squamous Cells in Liquid-Based Cervical Cytology: Microbiology, Inflammatory Infiltrate, and Human Papillomavirus-DNA Testing.
Gomes de Oliveira G; Eleutério RMN; Silveira Gonçalves AK; Giraldo PC; Eleutério J
Acta Cytol; 2018; 62(1):28-33. PubMed ID: 29130974
[TBL] [Abstract][Full Text] [Related]
17. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology.
Davey DD; Nielsen ML; Naryshkin S; Robb JA; Cohen T; Kline TS
Arch Pathol Lab Med; 1996 May; 120(5):440-4. PubMed ID: 8639046
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems.
Pirog EC; Erroll M; Harigopal M; Centeno BA
Arch Pathol Lab Med; 2004 May; 128(5):527-32. PubMed ID: 15086283
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
[TBL] [Abstract][Full Text] [Related]
20. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
